
Caristo Diagnostics Appoints New CCO and CFO to Accelerate AI Scaling
As Caristo Diagnostics targets a wider global footprint for its cardiovascular AI tools, the firm has tapped industry veterans David Vort and Chris Louk to lead its commercial and financial strategy. The appointments, effective immediately, arrive as the Oxford-born company pushes to integrate its diagnostic technologies into international clinical workflows.

























